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Introduction: Surface osteosarcoma are rare variant of osteosarcoma that include parosteal osteosarcoma,
periosteal osteosarcoma and high grade surface osteosarcoma. These lesions have different clinical
presentation and biological behavior compared to conventional osteosarcoma, and hence need to be
managed differently.
Goal: The aim of this study is to analyze the clinico-pathological features and outcome of a series of
surface osteosarcoma in an attempt to deﬁne the adequate treatment of this rare entity.
Patient and method: It is a retrospective and bicentric study of 18 surface osteosarcoma that were seen at
the KASSAB’s Institute and SAHLOUL Hospital from 2006 to 2013. The authors reviewed the clinical and
radiologic features, histologic sections, treatments, and outcomes in this group of patients.
Results: Seven patients were male (38.9%) and 11 were female (61.1%) with mean age of 25 years (range
from 16 to 55 years). Eleven lesions were in the femur and 7 in the tibia. We identiﬁed 11 parosteal
osteosarcoma (six of them were dedifferentiated), 3 periosteal osteosarcoma and 4 high grade surface
osteosarcoma. Six patients had neoadjuvant chemotherapy and all lesions had surgical resection. Margins
were wide in 15 cases and intra lesional in 3 cases. Histological response to chemotherapy was poor in all
cases. The mean follow up was 34.5 months. Six patients (33.3%) presented local recurrence and 8 pa-
tients (44.4%) presented lung metastases. Six patients (33.3%) died from the disease after a mean follow
up of 12 months (6–30 months); all of them had high grade lesions.
Conclusion: Histological grade of malignancy is the main point to assess in surface osteosarcoma since it
determines treatment and prognosis. Low grade lesions should be treated by wide resection, while high
grade lesions need more aggressive surgical approach associated to post operative chemotherapy.
& 2015 Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Level of evidence: IV
1.1. Introduction
Osteosarcoma are primary malignant bone tumors in
which neoplastic cells produce osteoid. The spectrum of le-
sions is very wide, which can be distinguished either by their
grade of malignancy, the differentiation of neoplastic cells or
even according to their location related to the bone. Most of
sarcoma arise intramedullarly, and only few of them develop
on the outer surface of the cortex when they are called “sur-
face osteosarcoma” [1]. They are classiﬁed into three sub-
types: parosteal osteosarcoma (POS), periosteal osteosarcomais an open access article under the
.(PerOS) and high grade surface osteosarcoma (HGSO). They
account for 5%, 1.5% and 0.5% of all osteosarcomas respectively
[2]. Classic parosteal osteosarcoma (cPOS) originates from the
outer ﬁbrous layer of the periosteum. Its cells are ﬁbroblasts.
It is characterized by the low grade of anaplasia and slow
indolent course. Occasionally, it presents a progression in
malignancy and becomes dedifferentiated (DPOS). Periosteal
osteosarcoma developes within the inner, germinative layer
of the periosteum (the cambium layer) from cells differ-
entiating in osteoblasts and chondroblasts. Its histological
grade of malignancy is intermediate. HGSO arises from the
surface of bone and it is entirely high grade, with a high
mitotic activity identical to that of conventional OS. We
report the clinical data and the oncological outcome of
18 cases of surface osteosarcoma and suggest the appropriate
management.CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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We reviewed retrospectively the clinical data of 18 patients
treated between 2006 and 2013 for a surface osteosarcoma. Patients
were managed in 2 centers: Kassab’s National Institute and Sahloul
Hospital. Clinical data were available from patients’ charts. Imaging
records and histological slides were reviewed and discussed re-
spectively with a radiologist and a pathologist that are specialized in
musculo-skeletal pathology. Inclusive criteria were bone sarcoma
producing osteoid originated at the surface of the bone regardless the
grade of malignancy and the degree of medullar extension. The mean
follow-up was 34.5 months (range: 6–96).
We analyzed the survival, local recurrence, and distant me-
tastasis outcomes using survivorship techniques. Duration of
symptoms was analyzed with t-test of student. We used Kaplan–
Meier survival analysis to determine the cumulative probability of
survival, survivorship free of recurrence, and survivorship free of
metastasis. Differences in survivorship curves were evaluated
using log-rank tests and p values less than 0.05 were considered
signiﬁcant. Statistical summaries, analyses, and plotting of survival
curves were performed using SPSS version 22.3. Results
3.1. Clinical ﬁndings
Seven patients were male (38.9%) and 11 were female (61.1%).
The mean age of patients was 25 years (range from 16 to 55 years).
All lesions involved the appendicular skeleton. Seven of them
(38.9%) were in the right side and 11 (61.1%) were in the left side.
The most common location was the knee (9 cases: 50%), with the
distal part of the femur involved in 8 cases. The duration of
symptoms before diagnosis ranged from 3 to 48 months (mean
12.6 months). cPOS had the longest duration compared to high
grade lesions (22.5 vs. 12.1 months). The most common symptom
was swelling, present in all patients. It was painful in 16 patients
(88.8%). Only 4 patients (22.2%) had joint stiffness, mainly knee
ﬂexum. Clinical data are summarized in Table 1.
3.2. Imaging features
Roentgenographic ﬁndings were analyzed for all patients. Se-
venteen patients had been evaluated with magnetic resonance
imaging and 10 patients had computed tomography.
Mainly, two patterns were observed. The ﬁrst one corre-
sponded to parosteal lesions and the second one to periosteal and
high grade surface lesions.
 Parosteal tumors were the most frequent ones with 11 cases
(61.1%). They had a predilection for the posterior cortex of the
distal metaphysis of the femur (8 cases: 72.7%). One case in-
volved the proximal metaphysis of the tibia and 2 cases were
diaphyseal: one in the femur (case 1) and one in the tibia.
Typically, the tumor had a melon-shaped, mineralized mass,
pasted on the cortex (Figs. 1a and 2a). The tumor size ranged
from 5 to 10 cm. The pattern of mineral was amorphous (50%)
(Fig. 1a), lobulated (40%) (Fig. 2a) or striated (10%). There was a
thin radiolucent zone between the tumor and the underlying
bone (Figs. 1a and 2a) in 81.1% of cases. A speculated periosteal
reaction was present in only one case (9%). The underlying
cortex was eroded or destroyed in 4 cases (36.3%). In the larger,
broad-based tumors, the cortex of the host bone was expanded
by a new-bone formation in 60% of cases. Medullary involve-
ment was clearly shown on plan radiographs in 5 cases (45.4%).
It was focal in 2 cases (Fig. 2a) and diffuse in 3 cases.Seven of these lesions were evaluated by CT scan wich was
useful to study the attachment of the tumor to the host bone,
medullary involvement and the presence of radiolucency within
the mineralized component (Figs. 1b and 2b).
MRI was available in 10 patients. It best evaluated local exten-
sion of the tumor and especially medullary involvement. This
was observed in 8 cases (72.7%). It was focal in 5 cases (Fig. 2c)
and diffuse in 3 cases.
Medullary extension was suspected radiologically in two cases
of the cPOS (50%) and in all cases (100%) of DPOS.
 The second pattern was that of PerOS (3 cases) and HGSO (4
cases). All lesions were diaphyseal and periosteal reaction was
constant. Typically, lesion had saucer shape appearance char-
acterized by a cortical thickening at the periphery with Codman
triangle and a non mineralized soft tissue mass at the center
(Figs. 3a and 4a). The soft tissue mass was characterized by an
aggressive periosteal reaction perpendicular to the osseous long
axis and causes scalloping that affected only the thickened
cortex (Fig. 3a). There was no abnormality in the adjacent
medullary canal. Fine ring calciﬁcations were seen in 3 cases
(42.8%) and they were related to the chondroblastic differentia-
tion of the lesion (Fig. 4a).
HGSO were radiologically more aggressive. While PerOS af-
fected only one part of the diaphyseal cylinder (Fig. 3a), HGSO
were circumferential in 2 cases (Fig. 4a). Soft tissue mass was less
mineralized in HGSO than in PerOS.
All patients were evaluated by MRI. Lesion margins were well
deﬁned with a pseudocapsule which corresponds to the periosteum
(Figs. 3b and 4b). The marrow signal intensity was normal in all pa-
tients with PerOS (Fig. 3b) and abnormal in HGSO (Fig. 4b and c). In
later cases, bone marrow invasion was focal in 3 cases (Fig. 4b) and
diffuse in one case. MR images obtained after intravenous gadolinium
administration showed a marked degree of enhancement in all pa-
tients. The enhancement pattern was the thick peripheral and septal
enhancement with nodularity pattern in all cases (Figs. 3b and 4c).
3.3. Histological ﬁndings
Tumors were classiﬁed into the following subtypes:
● Parosteal osteosarcoma (11 cases: 61.1%): Among parosteal tu-
mors, 5 (45.4%) were low grade lesions (cPOS) with hypocellular
spindle_cell stroma that contained well differentiated bone
trabiculae (Fig. 1f). Spindle cells showed minimum cytological
atypia and rare mitotic activity. Three lesions were graded 1 and
two graded 2. Four were ﬁbroblastic and one chondroblastic. In
one case, the osseous trabeculea of the neoplasm had cement
lines simulating the appearance of Paget disease and in one case
they had ﬁbrous dysplasia appearance.
Six of the parosteal osteosarcomas (54.6%) were considered to
have undergone dedifferentiation (DPOS); that is, a high grade
spindle cell sarcoma co-existed with a lower grade, more typical
parosteal osteosarcoma (Fig. 2e). Four cases were recognized at
the time of the initial diagnosis (synchronous lesions) and in
two cases, dedifferentiation occurred at the time of recurrence
(metachronous lesions). Cartilaginous component was identiﬁed
in 4 cases (66%). In two cases, cartilage was predominant. Three
cases were osteoblastic and one ﬁbroblastic.
Medullary involvement was observed histologically in only one
case in the group of cPOS, but was constant in the dediffer-
entiated lesions.
● Periosteal osteosarcomas (3 cases: 16.6%): Tumors were diagnosed
histologically as moderately differentiated (Grade 2 or 3). All
cases were predominantly chondroblastic (Fig. 3c). Bone marrow
was not invaded in any case.
Table 1
Clinical data and outcome of patients.
Patient Sex/age Location Duration of symtoms
(months)
Histological
diagnosis
Differentiation/
grade
Neo adjuvant chemotherapy: Yes
or No/response
Surgical management Margins Local recurrence/
treatment
Metastases Survival Follow up
1 M/30 DF 24 cPOS C/1 No Cortical resection IL Yes/ amputation No NED 30
2 F/25 FD 6 cPOS F/2 No Intercalary resection W No No NED 60
3 M/19 TD 36 cPOS F/1 No Cortical resection W No No NED 48
4 F/20 DF 24 cPOS F/1 No Prosthesis W No No NED 72
5 M/23 DF 12 cPOS F/2 No Knee arthrodesis W No No NED 12
6 F/55 DF 5 DPOS O/4 No Amputation W No No NED 20
7 F/27 DF 3 DPOS O/4 Yes/poor Knee arthrodesis W No Yes DOD 12
8 M/16 DF 6 DPOS O/4 Yes/poor Prosthesis W Yes/amputation Yes DOD 15
9 M/52 PT 48 DPOS C/3 No Prosthesis W No No NED 40
10 M/37 DF 4 DPOS O/4 Yes/poor Prosthesis W Yes Yes DOD 6
11 M/27 DF 24 DPOS F/4 Yes/poor Prosthesis W No Yes AWD 72
12 F/17 TD 6 PeOS C/3 No Cortical resection IL Yes/amputation No NED 24
13 F/16 FD 6 PeOS C/2 No Intercalary
reconstruction
W No No NED 72
14 M/17 TD 3 PeOS O/2 No Intercalary
reconstruction
W No No NED 18
15 F/19 FD 4 HGSO C/4 No Intercalary
reconstruction
IL Yes Yes DOD 6
16 F/16 FD 3 HGSO C/4 Yes/poor Intercalary
reconstruction
W Yes/amputation Yes DOD 30
17 F/16 TD 12 HGSO C/4 No Intercalary
reconstruction
W No Yes DOD 6
18 F/17 TD 18 HGSO C/4 Yes/poor Intercalary
reconstruction
W No Yes AWD 12
M: male; F: female; DF: distal femur; FD: femoral diaphysis; PT: proximal tibia; TD: tibial diaphysis; cPOS: classic parosteal osteosarcoma; DPOS: dedifferentiated parosteal osteosarcoma; PeOS: periosteal osteosarcoma; HGSO: high
grade surface osteosarcoma; C: chondroblastic; F: ﬁbroblastic; O: osteoblastic; IL: intralesional; W: wide; NED: no evidence of disease; DOD: dead of disease; AWD: alive with disease.
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Fig. 1. Case 1: parosteal osteosarcoma in a 24-year-old patient: (a) AP radiograph of the right femur shows an ossiﬁed exophytic tumor on the surface of the femur. A lucent
cleavage plane (arrow) is seen between the tumor and the underlying cortex. (b) Transversal CT image in soft tissue algorithm: ossiﬁed lesion developed at the surface of
bone cortex with hypodense peripheral rim. (c) Transversal T1 MR image after Gadolinium administration and (d) sagittal T2 image. The lesion shows low T1 and T2 intensity
with peripheral enhancement but no adjacent bone signal abnormality. (e) Gross specimen showing a large, gritty white mass pasted on the underlying cortex with no
medullary invasion. The cut surface displayed a homogeneous appearance with lucent areas. A thin lucent line ( arrow) is seen between the tumor and bone and corresponds
to the periosteum. (f) Lower-power photomicrograph showing a well-formed bony trabeculae in a hypocellular spindle cell stroma. The tumor is low grade attested by the
slight nuclear pleomorphism of the cellular component (hematoxylin and eosin 25 ).
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Fig. 2. Case 2: DPOS in a 54-year-old male: (a) AP radiograph of the right knee shows an ossiﬁed tumor in medial proximal tibia with a lucent cleavage plane at its edge (arrow).
(b) Coronal CT view of the right knee: surface bone lesion developed on the proximal tibia cortex. The lesion presents a proximal ossiﬁed (O) and distal hypodense (NO)
appearance and is partially separated from bone by a hypodense thin band. (c) Transversal T1 MR image: the lesion presents a low T1 signal intensity and extends through
the cortex to the bone marrow (arrowhead). (d) Gross specimen showing a nonhomogneous appearance of the DPOS. The tumor is composed of a mainly lytic (arrows), ivory
areas intermixed with tan areas (arrow head) located close to the cortex and penetrate focally into the medullary canal (star). (e) Lower-power photomicrograph showing a
conventional parosteal osteosarcoma to the right and area of dedifferentiation with pleomorphic appearing nuclei to the left (hematoxylin and eosin, 25 ). Note the
anastomosing arrangement of mature bony trabeculae with stromal cells in between. The dedifferentiation component corresponds to a high-grade spindle cell sarcoma. The
transition between the two components is abrupt.
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grade 4 on Broder’s scale (Fig. 4e). Three cases were chondro-
blastic (Fig. 4f) and one osteoblastic. Tumors were very permea-
tive and involvement of bone marrow was observed in all cases
(Fig. 4d).
3.4. Treatment Surgical procedures: All patients underwent surgical resection.
For diaphyseal tumors (9 cases), we performed cylindrical re-
section and intercalary reconstruction in 7 cases and partial
resection of the cortex in two cases.
For metaphyseal and epiphyseal tumors (9 cases), we per-
formed epiphyseal resection and reconstruction with en-
doprosthesis in 5 cases, knee arthrodesis in two cases, resection
of the posterior cortex of the distal femur with bone grafting inone case and above the knee amputation in one case. Margins
were considered wide in 15 cases and intralesional in 3 cases.
 Chemotherapy: 10 patients with high grade lesions (DPOS or
HGS) received modern protocols of chemotherapy incorporating
doxorubicin and methotrexate. Six of them received pre and
post operative chemotherapy, and 4 patients received only post
operative chemotherapy. Response to chemotherapy in patients
that received neoadjuvant was poor in all cases.
3.5. Local control
There were 6 cases of local recurrence (33.3%). Three cases were
secondary to intralesional resections and three cases were observed after
wide resections. In the latter cases, tumors were of a high grade (2 DPOS
and 1 HGSO). Local recurrences were treated by amputation in 5 cases.
The mean survival period without local recurrence was
48.577.31 months. The survival rates without local recurrence at
Fig. 3. Case 3: periosteal osteosarcoma in a 16-year-old female: (a) AP radiograph of the left femur shows a surface bone tumor of the femoral diaphysis with cortical
thickening and mostly at its edges (stars) and perpendicular peri-osteal spicules in the center (arrow) giving a tipical saucer-shape appearance. (b) Coronal T1 MR image after
intravenous Gadolinium administration showing a surface bone lesion of the proximal femoral diaphysis with heterogenous MR signal, thickened cortex (stars) and no bone
marrow abnormality. (c) Lower-power photomicrograph showing a periosteal osteosarcoma. The tumor is predominatly cartilaginous and the lace-like osteoid (stars)
production is reduced (hematoxylin and eosin, 40 ).
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without local recurrence at 5 years for low garde tumors (cPOS and
PerOS) and in high grade tumors (DPOS and HGSO) were respec-
tively 80% and 34.1%. The univariate analysis showed no signiﬁcant
difference (p¼0.07).3.6. Metastases
Seven patients (38.8%) developed lung metastases. All of them
had high grade tumors (3 DPOS and 4 HGSO). Three patient had
metastasectomy associated to chemotherapy and 4 patients had
chemotherapy only.The mean survival period without metastases was 47.4277.71
months. The survival rates without metastases at 2 and 5 years
were respectively 66.02% and 38.6%. The survival rates without
metastases at 5 years for low garde tumors (cPOS and PerOS) and
in high grade tumors (DPOS and HGSO) were respectively 100%
and between 20% and 40%. The univariate analysis showed that
histologic grade is a prognostic factor for metastases (p¼0.004).
3.7. Survival
Twelve patients (66.7%) were still alive, and six (33.3%) died
secondary to lung metastases after a mean time from surgery of
15.6 months (range: 6–30).
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Fig. 4. Case 4: High grade surface osteosarcoma in a 16-year-old female: (a) AP radiograph of the left femur: soft tissue swelling with chondroïd matrix (C) circonferential to
the distal femur shaft. Note the periosteal bone formation with codman triangle (arrows). (b, c) MRI (sagittal T2 and coronal T1 image after fat suppression and intravenous
Gadolinium administration) shows a low T1 and high T2 tumor mostly developed around the bone surface with cortical scalopping (S) and bone marrow signal abnormality
(arrow head). (d) Gross specimen showing a huge circumferential white to grayish tumor. The tumor is mainly composed of lobulated chondroïd areas (C). The tumor
develops in the deeper part of the periosteum and shows lifting of the periosteum (arrows). Bone marrows invasion (arrow head) High grade surface osteosarcoma wich
shows prédominent chondroblastic differentiation: (e) photomicrograph showing large amounts of bone with spindle-cell stroma between the osseous trabeculae.
(f) Photomicrograph showing the cartilaginous component with an irregular arrangement of chondrocytes.
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The survival rates at 2 and 5 years were respectively 71.3% and
62.4%. For low garde tumors (cPOS and PerOS) the survival rate
without death was 100% while in high grade tumors (DPOS and
HGSO) it was 35.4% (Fig. 5). The univariate analysis showed that
malignancy grade was signiﬁcantly related to prognosis (p¼0.018).
Table 2 resumes statistical data.4. Discussion
Our study is limited by the low number of cases reported. This
is due to the rarity of surface osteosarcoma. These cases re-
presented only 17.5% of all osteosarcoma treated in the same
period in both centers. The most frequent lesion observed in our
series was POS which represented 61% of surface osteosarcoma
and 11% of all osteosarcoma. PerOS and HGSO represented each of
them respectively 16.6% and 22.2% of surface osteosarcoma and
3.2% and 3.4 of all osteosarcoma.In the literature, the proportion of surface osteosarcoma is
much lower. They do not exceed 8% of all osteosarcoma. cPOS is
the most frequent lesion with about 5% of all osteosarcoma [okada,
campanacci]. PerOS and HGSO are much more unfrequent and
represent respectively 1–2% and 0.5% of all osteosarcoma. The high
rate of DPOS and HGSO reported in our series is probably related
to the fact that we did not exclude cases with medullary extension
which precludes the diagnosis of surface osteosarcoma for some
authors [2,3]. We think that the frequency of HGSO and DPOS are
under estimated in the literature. Due to the permeative pattern
and the rapid evolution of these lesions, a large number of them
are misdiagnosed as convetional osteosarcoma.
Clinical history of patients with surface osteosarcoma depends
on its grade of malignancy. In low grade lesions and especially in
cPOS, symptoms are most often of prolonged duration [3]. How-
ever, in HGSO and DPOS—especially when the dedifferentiation is
synchronous—clinical history is not distinguishable from that of
conventional osteosarcoma. In our study, the mean duration of
symptoms was longer in low and intermediate grade lesions than
Fig. 5. Survival rate without death according the malignancy differentiation (low
grade: cPOS and PerOS, high grade: DPOS and HGSO)).
Table 2
Statistic data.
Low and intermediate
grade tumors
High grade
tumors
p-value
5 years survival rate with
local recurrence
80% 34.1% 0.07
5 years survival rate with
metastases
100% 20–40% 0.004
5 years survival rate with
death
100% 35.4% 0.018
Mean duration of
symptoms
1674.66 months 1274.14
months
0.56
H. Nouri et al. / Journal of Bone Oncology 4 (2015) 115–123122in high grade lesions (1674.66 months vs. 1274.14 months).
However the difference was not statistically signiﬁcant.
Radiologically, we observed two patterns corresponding to
mainly 2 lesions: parosteal osteosarcoma in one hand and PerOS
and HGSO in the other hand.
Distinctive features between cPOS and DPOS are debatable. As
observed in our series (25% vs. 100%), invasion of the medullary
canal is more frequent in cPOS then in DPOS [3,4]. However, this
cannot distinguish DPOS from cPOS according to Sheth et al. [5].
Other distinctive features were reported. Bertoni [6] studied the
meaning of radioloucencies in parosteal osteosarcomas and con-
cluded that the presence of deep intralesional radiolucencies
within a parosteal osteosarcoma strongly suggests the possibility
that the lesion is dedifferentiated.
Medullary involvement is also discussed in periosteal osteo-
sarcomas and HGSO. Some authors think that this sign precludes
the diagnosis of surface osteosarcoma [7] while others have de-
scribed periosteal osteosarcoma with microscopic or gross me-
dullary involvement [8,9].
Histologically, diagnosis of cPOS can be overlopped with other
lesions as fracture callus, ﬁbrous dysplasia and Paget disease.
Clinical history and radiological features are very helpful. Due to
the chondroblastic differentiation, PerOS can sometimes be con-
fused with chondrosarcoma and especially malignant transfor-
mation of an exostosis. Here also radiological appearance of the
lesion is distinctive.
Currently, surgery is the main therapeutic procedure for surface
osteosarcoma. Wide resection is recommended to achieve safemargins. Some authors advocated local excision for cPOS with
marginal margins [10–12]. Indeed, resection of the cortical on
which the cPOS is developed when the medullary canal is not
invaded can be safe. Two cases had cortical resection with wide
margins did not recur in our series. However, intralesional resec-
tion is absolutely prohibited because it is associated with high rate
of local recurrence and high risk of dedifferentiation. In our ex-
perience, all cases in which resection was intralesional recurred. In
one case, the tumor underwent dedifferentiation 4 years after ﬁrst
excision.
For high grade lesions (DPOS and HGSO), margins have to be as
wide as possible in. One of the problems of these lesions is the
assessment of the true extension of the tumor in the subperiosteal
plane. According to Revell [9], even with axial MRI and CT, this can
be difﬁcult. These tumors are very permeative and spread further
than can be assessed by MRI, and hence wider margins than might
at ﬁrst be considered are mandatory for safety. In the current
study, three lesions recurred despite wide resections.
Chemotherapy has limited beneﬁt in surface osteosarcoma.
Rose [3] showed no beneﬁt of chemotherapy in PerOS. Degree of
necrosis that he observed in patients that received doxorobucine,
ifosfamide and methotrexate was similar to the spontaneous ne-
crosis seen in resected specimens from the other patients. Bertoni
[4] reported poor response in all patients with DPOS that received
neoadjuvant chemotherapy. Even for survival rate, the role of
chemotherapy was not clear. Revel [5] reviews a series of 17 PerOS.
Among 10 patients who received neoadjuvant chemotherapy, only
2 had greater than 90% necrosis. Although, both authors [4,5] re-
commended by caution the use of neoadjuvant chemotherapy for
DPOS and PerOS respectively.
To our opinion, chemotherapy should be used only in high
grade lesions (DPOS and HGSO). Furthermore and due to the
amount of poor response and especially the high risk of progres-
sion of the disease during chemotherapy, it would be safer and so
recommendable to use chemotherapy post operatively only.
Prognosis of surface osteosarcomas is mainly related to histo-
logical grade. The probability of metastasis is signiﬁcantly related
to dedifferentiation. The second most important factor is surgical
margins. Intralesional and marginal resections are associated to a
high rate of recurrence and hence a progression of malignancy.5. Conclusion
Surface osteosarcomas are rare but they cover a wide spectrum
of lesions. We think that there are 2 kinds of lesions:
 parosteal tumors that develop from the outer part of the péri-
osteum and include cPOS and DPOS
 and periosteal tumors that develop from the inner part of the
periosteum and include PerOS and HGSO.
Histological grade of malignancy is the main point to assess
since it determines treatment and prognosis. Low and inter-
mediate grade lesions (cPOS and PerOS) should be treated by wide
resection, however high grade lesions (DPOS and HGSO) need
more aggressive surgical approach associated to post operative
chemotherapy.Conﬂict of interest
None.
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